Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Till Junker"'
Autor:
Michael Medinger, Till Junker, Dominik Heim, Alexandar Tzankov, Philip M. Jermann, Maria Bobadilla, Michele Vigolo, Rajwinder Lehal, Florian D. Vogl, Michael Bauer, Jakob Passweg
Publikováno v:
eJHaem, Vol 3, Iss 3, Pp 1009-1012 (2022)
Abstract Relapsed T cell acute lymphoblastic leukaemia (T‐ALL) has a very poor prognosis. A 24‐year‐old patient with relapsed high‐risk T‐ALL (PTEN gene deletion; NOTCH1 mutation), was treated with the NOTCH inhibitor CB‐103. Within 1 wee
Externí odkaz:
https://doaj.org/article/06e153db5bae43668267f8a8964d3c11
Autor:
Luca Valore, Till Junker, Eva Heilmann, Christine S. Zuern, Matthias Streif, Beatrice Drexler, Christian Arranto, Jörg P. Halter, Christoph T. Berger
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
IntroductionVaccine-induced myocarditis is a rare complication of messenger RNA (mRNA) COVID-19 vaccines.Case presentationWe report a case of acute myopericarditis in a recipient of allogeneic hematopoietic cells following the first dose of the mRNA-
Externí odkaz:
https://doaj.org/article/03011313d1824b06a19ac766351c01a5
Autor:
Davide Spica, Till Junker, Michael Dickenmann, Stefan Schaub, Jürg Steiger, Tanja Rüfli, Jörg Halter, Helmut Hopfer, Andreas Holbro, Patricia Hirt-Minkowski
Publikováno v:
Case Reports in Nephrology and Dialysis, Vol 9, Iss 3, Pp 149-157 (2019)
We report the effectiveness of daratumumab, a human IgGκ monoclonal antibody targeting CD38 on plasma cells, for therapy-refractory antibody-mediated rejection (AMR) due to blood group antibodies in a 59-year-old man who received a living ABO-incomp
Externí odkaz:
https://doaj.org/article/2858f123c09f48e183e733ae3731a530
Autor:
VERA DALLA VIA, ANNE STELMES, MIKE RECHER, CHRISTIAN ARRANTO, TILL JUNKER, FRANCESCA MATTEAZZI, DOMINIK HEIM, JAKOB R. PASSWEG, MICHAEL MEDINGER, JANA VAN DEN BERG
Publikováno v:
Anticancer Research. 42:4505-4509
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90662388960bad9c4fcd70dc5bd3b6ca
https://doi.org/10.21873/anticanres.15952
https://doi.org/10.21873/anticanres.15952
Autor:
Astrid Beerlage, Karoline Leuzinger, Luca Valore, Roby Mathew, Till Junker, Beatrice Drexler, Jakob R. Passweg, Hans H. Hirsch, Jörg Halter
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation Society. 24(3)
Patients after allogeneic stem cell transplantation are at high risk for infection-related complications, and vaccination efficacy might be impaired depending on the immune reconstitution. In this study, we evaluate their response to mRNA vaccines ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bd4bde5eda5af7c27ddb11d60aed904
https://pubmed.ncbi.nlm.nih.gov/35419913
https://pubmed.ncbi.nlm.nih.gov/35419913